tiprankstipranks
D-Wave Quantum Advances Drug Discovery with JT Partnership
Company Announcements

D-Wave Quantum Advances Drug Discovery with JT Partnership

Don't Miss our Black Friday Offers:

D-Wave Quantum ( (QBTS) ) has issued an update.

D-Wave Quantum Inc. and Japan Tobacco Inc.’s pharmaceutical division are teaming up to revolutionize drug discovery by integrating quantum computing and AI. Their joint proof-of-concept project is designed to enhance the speed and effectiveness of AI in identifying new ‘first-in-class’ small molecule pharmaceuticals. D-Wave’s expertise in quantum computing will be leveraged to expand the capabilities of JT’s AI systems, potentially setting a new standard in the pharmaceutical industry and accelerating the development of innovative drugs.

Find detailed analytics on QBTS stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyD-Wave Quantum price target raised to $3 from $2 at Roth MKM
TipRanks Auto-Generated NewsdeskD-Wave Quantum Growth Amidst Revenue Challenges
TheFlyD-Wave Quantum sees FY24 adjusted EBITDA loss less than last year’s $54.3M
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App